Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 861 entries
Sorted by: Best Match Show Resources per page
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial.

Contemporary clinical trials communications

Bird SM, Strang J, Ashby D, Podmore J, Robertson JR, Welch S, Meade AM, Parmar MKB.
PMID: 28424796
Contemp Clin Trials Commun. 2017 Mar;5:100-106. doi: 10.1016/j.conctc.2017.01.006.

The prison-based N-ALIVE pilot trial had undertaken to notify the Research Ethics Committee and participants if we had reason to believe that the N-ALIVE pilot trial would not proceed to the main trial. In this paper, we describe how...

Cite
Bird SM, Strang J, Ashby D, et al. External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemp Clin Trials Commun. 2017;5:100-106doi: 10.1016/j.conctc.2017.01.006.
Bird, S. M., Strang, J., Ashby, D., Podmore, J., Robertson, J. R., Welch, S., Meade, A. M., & Parmar, M. K. B. (2017). External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemporary clinical trials communications, 5100-106. https://doi.org/10.1016/j.conctc.2017.01.006
Bird, Sheila M, et al. "External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial." Contemporary clinical trials communications vol. 5 (2017): 100-106. doi: https://doi.org/10.1016/j.conctc.2017.01.006
Bird SM, Strang J, Ashby D, Podmore J, Robertson JR, Welch S, Meade AM, Parmar MKB. External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemp Clin Trials Commun. 2017 Mar;5:100-106. doi: 10.1016/j.conctc.2017.01.006. PMID: 28424796; PMCID: PMC5389338.
Copy Download .nbib Format: NLM
Real-Time Enrollment Dashboard For Multisite Clinical Trials.

Contemporary clinical trials communications

Mattingly WA, Kelley RR, Wiemken TL, Chariker JH, Peyrani P, Guinn BE, Binford LE, Buckner K, Ramirez J.
PMID: 26878068
Contemp Clin Trials Commun. 2015 Oct 30;1:17-21. doi: 10.1016/j.conctc.2015.09.001.

OBJECTIVE: Achieving patient recruitment goals are critical for the successful completion of a clinical trial. We designed and developed a web-based dashboard for assisting in the management of clinical trial screening and enrollment.MATERIALS AND METHODS: We use the dashboard...

Cite
Mattingly WA, Kelley RR, Wiemken TL, et al. Real-Time Enrollment Dashboard For Multisite Clinical Trials. Contemp Clin Trials Commun. 2015;1:17-21doi: 10.1016/j.conctc.2015.09.001.
Mattingly, W. A., Kelley, R. R., Wiemken, T. L., Chariker, J. H., Peyrani, P., Guinn, B. E., Binford, L. E., Buckner, K., & Ramirez, J. (2015). Real-Time Enrollment Dashboard For Multisite Clinical Trials. Contemporary clinical trials communications, 117-21. https://doi.org/10.1016/j.conctc.2015.09.001
Mattingly, William A, et al. "Real-Time Enrollment Dashboard For Multisite Clinical Trials." Contemporary clinical trials communications vol. 1 (2015): 17-21. doi: https://doi.org/10.1016/j.conctc.2015.09.001
Mattingly WA, Kelley RR, Wiemken TL, Chariker JH, Peyrani P, Guinn BE, Binford LE, Buckner K, Ramirez J. Real-Time Enrollment Dashboard For Multisite Clinical Trials. Contemp Clin Trials Commun. 2015 Oct 30;1:17-21. doi: 10.1016/j.conctc.2015.09.001. PMID: 26878068; PMCID: PMC4746719.
Copy Download .nbib Format: NLM
A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study.

Contemporary clinical trials communications

Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH.
PMID: 29682627
Contemp Clin Trials Commun. 2018 Jun;10:1-8. doi: 10.1016/j.conctc.2018.02.001.

OBJECTIVE: Exercise is a promising treatment for substance use disorders, yet an intention-to-treat analysis of a large, multi-site study found no reduction in stimulant use for exercise versus health education. Exercise adherence was sub-optimal; therefore, secondary post-hoc complier average...

Cite
Carmody T, Greer TL, Walker R, et al. A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study. Contemp Clin Trials Commun. 2018;10:1-8doi: 10.1016/j.conctc.2018.02.001.
Carmody, T., Greer, T. L., Walker, R., Rethorst, C. D., & Trivedi, M. H. (2018). A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study. Contemporary clinical trials communications, 101-8. https://doi.org/10.1016/j.conctc.2018.02.001
Carmody, Thomas, et al. "A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study." Contemporary clinical trials communications vol. 10 (2018): 1-8. doi: https://doi.org/10.1016/j.conctc.2018.02.001
Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH. A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study. Contemp Clin Trials Commun. 2018 Jun;10:1-8. doi: 10.1016/j.conctc.2018.02.001. PMID: 29682627; PMCID: PMC5898532.
Copy Download .nbib Format: NLM
Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials.

Contemporary clinical trials communications

Devine EG, Peebles KR, Martini V.
PMID: 29740622
Contemp Clin Trials Commun. 2016 Dec 18;5:67-71. doi: 10.1016/j.conctc.2016.12.005. eCollection 2017 Mar.

Clinical trials within the US face an increasing challenge with the recruitment of quality candidates. One readily available group of subjects that have high rates of participation in clinical research are subjects who enroll in multiple trials for the...

Cite
Devine EG, Peebles KR, Martini V. Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials. Contemp Clin Trials Commun. 2016;5:67-71doi: 10.1016/j.conctc.2016.12.005.
Devine, E. G., Peebles, K. R., & Martini, V. (2017). Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials. Contemporary clinical trials communications, 567-71. https://doi.org/10.1016/j.conctc.2016.12.005
Devine, Eric G, et al. "Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials." Contemporary clinical trials communications vol. 5 (2017): 67-71. doi: https://doi.org/10.1016/j.conctc.2016.12.005
Devine EG, Peebles KR, Martini V. Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials. Contemp Clin Trials Commun. 2016 Dec 18;5:67-71. doi: 10.1016/j.conctc.2016.12.005. eCollection 2017 Mar. PMID: 29740622; PMCID: PMC5936691.
Copy Download .nbib Format: NLM
Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions.

Contemporary clinical trials communications

Vuijk R, Arntz A.
PMID: 29740624
Contemp Clin Trials Commun. 2017 Jan 06;5:80-85. doi: 10.1016/j.conctc.2017.01.001. eCollection 2017 Mar.

BACKGROUND: To our knowledge treatment of personality disorder (PD) comorbidity in adults with ASD is understudied and is still in its infancy. This study investigates the effectiveness of schema therapy for PD-psychopathology in adult patients with both ASD and...

Cite
Vuijk R, Arntz A. Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions. Contemp Clin Trials Commun. 2017;5:80-85doi: 10.1016/j.conctc.2017.01.001.
Vuijk, R., & Arntz, A. (2017). Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions. Contemporary clinical trials communications, 580-85. https://doi.org/10.1016/j.conctc.2017.01.001
Vuijk, Richard, and Arntz, Arnoud. "Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions." Contemporary clinical trials communications vol. 5 (2017): 80-85. doi: https://doi.org/10.1016/j.conctc.2017.01.001
Vuijk R, Arntz A. Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions. Contemp Clin Trials Commun. 2017 Jan 06;5:80-85. doi: 10.1016/j.conctc.2017.01.001. eCollection 2017 Mar. PMID: 29740624; PMCID: PMC5936690.
Copy Download .nbib Format: NLM
Protocol for evaluating a workplace intervention within the framework of consultations for suffering at work in French-speaking Switzerland.

Contemporary clinical trials communications

Mediouni Z, Barlet-Ghaleb C, Zenoni M, Rinaldo M, Grolimund Berset D, Eich S, Danuser B, Krief P.
PMID: 31312747
Contemp Clin Trials Commun. 2019 Jun 27;15:100400. doi: 10.1016/j.conctc.2019.100400. eCollection 2019 Sep.

INTRODUCTION: Psychosocial suffering involves diverse human, social and economic costs. Some 34.4% of workers in Switzerland report chronic stress related to their jobs. Medical consultations for suffering at work aim to maintain-or renew-patients' abilities to make decisions and act...

Cite
Mediouni Z, Barlet-Ghaleb C, Zenoni M, et al. Protocol for evaluating a workplace intervention within the framework of consultations for suffering at work in French-speaking Switzerland. Contemp Clin Trials Commun. 2019;15:100400doi: 10.1016/j.conctc.2019.100400.
Mediouni, Z., Barlet-Ghaleb, C., Zenoni, M., Rinaldo, M., Grolimund Berset, D., Eich, S., Danuser, B., & Krief, P. (2019). Protocol for evaluating a workplace intervention within the framework of consultations for suffering at work in French-speaking Switzerland. Contemporary clinical trials communications, 15100400. https://doi.org/10.1016/j.conctc.2019.100400
Mediouni, Z, et al. "Protocol for evaluating a workplace intervention within the framework of consultations for suffering at work in French-speaking Switzerland." Contemporary clinical trials communications vol. 15 (2019): 100400. doi: https://doi.org/10.1016/j.conctc.2019.100400
Mediouni Z, Barlet-Ghaleb C, Zenoni M, Rinaldo M, Grolimund Berset D, Eich S, Danuser B, Krief P. Protocol for evaluating a workplace intervention within the framework of consultations for suffering at work in French-speaking Switzerland. Contemp Clin Trials Commun. 2019 Jun 27;15:100400. doi: 10.1016/j.conctc.2019.100400. eCollection 2019 Sep. PMID: 31312747; PMCID: PMC6609781.
Copy Download .nbib Format: NLM
[No title available]

Contemporary clinical trials communications

McKee LG, Algoe SB, Faro AL, O'Leary JL, O'Neal CW.
PMID: 31372571
Contemp Clin Trials Commun. 2019 Jun 29;15:100391. doi: 10.1016/j.conctc.2019.100391. eCollection 2019 Sep.

Research shows that daily experiences of awe, curiosity, gratitude, joy, and love can put the average person on a trajectory of growth, success, and positive social connection, and can also prevent those who are suffering from following a downward...

Cite
McKee LG, Algoe SB, Faro AL, et al. . Contemp Clin Trials Commun. 2019;15:100391doi: 10.1016/j.conctc.2019.100391.
McKee, L. G., Algoe, S. B., Faro, A. L., O'Leary, J. L., & O'Neal, C. W. (2019). . Contemporary clinical trials communications, 15100391. https://doi.org/10.1016/j.conctc.2019.100391
McKee, Laura G, et al. "." Contemporary clinical trials communications vol. 15 (2019): 100391. doi: https://doi.org/10.1016/j.conctc.2019.100391
McKee LG, Algoe SB, Faro AL, O'Leary JL, O'Neal CW. . Contemp Clin Trials Commun. 2019 Jun 29;15:100391. doi: 10.1016/j.conctc.2019.100391. eCollection 2019 Sep. PMID: 31372571; PMCID: PMC6658827.
Copy Download .nbib Format: NLM
Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women.

Contemporary clinical trials communications

Buist DSM, Tiro JA, Thayer C, Beatty T, Miglioretti DL, Lin J, Winer RL.
PMID: 31372572
Contemp Clin Trials Commun. 2019 Jul 19;15:100413. doi: 10.1016/j.conctc.2019.100413. eCollection 2019 Sep.

Despite increased attention on how to conduct pragmatic trials and their importance, there remains an under-appreciation for the reality of what they take to design, compete and secure funding and execute. Many barriers are surmountable through increased exposure to...

Cite
Buist DSM, Tiro JA, Thayer C, et al. Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women. Contemp Clin Trials Commun. 2019;15:100413doi: 10.1016/j.conctc.2019.100413.
Buist, D. S. M., Tiro, J. A., Thayer, C., Beatty, T., Miglioretti, D. L., Lin, J., & Winer, R. L. (2019). Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women. Contemporary clinical trials communications, 15100413. https://doi.org/10.1016/j.conctc.2019.100413
Buist, D S M, et al. "Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women." Contemporary clinical trials communications vol. 15 (2019): 100413. doi: https://doi.org/10.1016/j.conctc.2019.100413
Buist DSM, Tiro JA, Thayer C, Beatty T, Miglioretti DL, Lin J, Winer RL. Improving the promise of embedded pragmatic trials: Surmountable barriers encountered in an evaluation of home-based HPV self-sampling to increase cervical cancer screening in overdue women. Contemp Clin Trials Commun. 2019 Jul 19;15:100413. doi: 10.1016/j.conctc.2019.100413. eCollection 2019 Sep. PMID: 31372572; PMCID: PMC6661276.
Copy Download .nbib Format: NLM
Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial.

Contemporary clinical trials communications

Chalela P, Munoz E, Inupakutika D, Kaghyan S, Akopian D, Kaklamani V, Lathrop K, Ramirez A.
PMID: 30377674
Contemp Clin Trials Commun. 2018 Oct 17;12:109-115. doi: 10.1016/j.conctc.2018.10.001. eCollection 2018 Dec.

Adjuvant endocrine hormonal therapy (EHT) is highly effective and appropriate for nearly all breast cancer patients with hormone receptor-positive tumors, which represent 75% of all breast cancer diagnoses. Long-term use of EHT reduces recurrence rates and nearly halves the...

Cite
Chalela P, Munoz E, Inupakutika D, et al. Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2018;12:109-115doi: 10.1016/j.conctc.2018.10.001.
Chalela, P., Munoz, E., Inupakutika, D., Kaghyan, S., Akopian, D., Kaklamani, V., Lathrop, K., & Ramirez, A. (2018). Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemporary clinical trials communications, 12109-115. https://doi.org/10.1016/j.conctc.2018.10.001
Chalela, P, et al. "Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial." Contemporary clinical trials communications vol. 12 (2018): 109-115. doi: https://doi.org/10.1016/j.conctc.2018.10.001
Chalela P, Munoz E, Inupakutika D, Kaghyan S, Akopian D, Kaklamani V, Lathrop K, Ramirez A. Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2018 Oct 17;12:109-115. doi: 10.1016/j.conctc.2018.10.001. eCollection 2018 Dec. PMID: 30377674; PMCID: PMC6202663.
Copy Download .nbib Format: NLM
Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18].

Contemporary clinical trials communications

Vohra S, Schlegelmilch M, Jou H, Hartfield D, Mayan M, Ohinmaa A, Wilson B, Spavor M, Grundy P.
PMID: 29741163
Contemp Clin Trials Commun. 2017 Apr 21;6:147. doi: 10.1016/j.conctc.2017.04.004. eCollection 2017 Jun.

[This corrects the article DOI: 10.1016/j.conctc.2016.11.002.].

Cite
Vohra S, Schlegelmilch M, Jou H, et al. Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18]. Contemp Clin Trials Commun. 2017;6:147doi: 10.1016/j.conctc.2017.04.004.
Vohra, S., Schlegelmilch, M., Jou, H., Hartfield, D., Mayan, M., Ohinmaa, A., Wilson, B., Spavor, M., & Grundy, P. (2017). Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18]. Contemporary clinical trials communications, 6147. https://doi.org/10.1016/j.conctc.2017.04.004
Vohra, Sunita, et al. "Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18]." Contemporary clinical trials communications vol. 6 (2017): 147. doi: https://doi.org/10.1016/j.conctc.2017.04.004
Vohra S, Schlegelmilch M, Jou H, Hartfield D, Mayan M, Ohinmaa A, Wilson B, Spavor M, Grundy P. Corrigendum to "Comparative effectiveness of pediatric integrative medicine as an adjunct to usual care for pediatric inpatients of a North American tertiary care centre: A study protocol for a pragmatic cluster controlled trial" [Contemp. Clin. Trials Commun. (2017) 12-18]. Contemp Clin Trials Commun. 2017 Apr 21;6:147. doi: 10.1016/j.conctc.2017.04.004. eCollection 2017 Jun. PMID: 29741163; PMCID: PMC5936798.
Copy Download .nbib Format: NLM
The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale.

Contemporary clinical trials communications

Shah B, Ganguzza L, Slater J, Newman JD, Allen N, Fisher E, Larigakis J, Ujueta F, Gianos E, Guo Y, Woolf K.
PMID: 29333503
Contemp Clin Trials Commun. 2017 Dec;8:90-98. doi: 10.1016/j.conctc.2017.09.003. Epub 2017 Sep 14.

BACKGROUND: Multiple studies demonstrate the benefit of a vegan diet on cardiovascular risk factors when compared to no intervention or usual dietary patterns. The aim of this study is to evaluate the effect of a vegan diet versus the...

Cite
Shah B, Ganguzza L, Slater J, et al. The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale. Contemp Clin Trials Commun. 2017;8:90-98doi: 10.1016/j.conctc.2017.09.003.
Shah, B., Ganguzza, L., Slater, J., Newman, J. D., Allen, N., Fisher, E., Larigakis, J., Ujueta, F., Gianos, E., Guo, Y., & Woolf, K. (2017). The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale. Contemporary clinical trials communications, 890-98. https://doi.org/10.1016/j.conctc.2017.09.003
Shah, Binita, et al. "The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale." Contemporary clinical trials communications vol. 8 (2017): 90-98. doi: https://doi.org/10.1016/j.conctc.2017.09.003
Shah B, Ganguzza L, Slater J, Newman JD, Allen N, Fisher E, Larigakis J, Ujueta F, Gianos E, Guo Y, Woolf K. The Effect of a Vegan versus AHA DiEt in Coronary Artery Disease (EVADE CAD) trial: study design and rationale. Contemp Clin Trials Commun. 2017 Dec;8:90-98. doi: 10.1016/j.conctc.2017.09.003. Epub 2017 Sep 14. PMID: 29333503; PMCID: PMC5764176.
Copy Download .nbib Format: NLM
Rationale and design of a feasibility and acceptability RCT of romantic partner and support figure attendance during bariatric surgery visits.

Contemporary clinical trials communications

Ferriby M, Pratt K, Wallace L, Focht BC, Noria S, Needleman B.
PMID: 31388601
Contemp Clin Trials Commun. 2019 Jul 24;15:100422. doi: 10.1016/j.conctc.2019.100422. eCollection 2019 Sep.

As US obesity rates increase, more patients, particularly females, are seeking out bariatric surgery. As bariatric surgery patients' social supports have been vastly understudied, clinicians and researchers have limited information about how to include support figures, including romantic partners,...

Cite
Ferriby M, Pratt K, Wallace L, et al. Rationale and design of a feasibility and acceptability RCT of romantic partner and support figure attendance during bariatric surgery visits. Contemp Clin Trials Commun. 2019;15:100422doi: 10.1016/j.conctc.2019.100422.
Ferriby, M., Pratt, K., Wallace, L., Focht, B. C., Noria, S., & Needleman, B. (2019). Rationale and design of a feasibility and acceptability RCT of romantic partner and support figure attendance during bariatric surgery visits. Contemporary clinical trials communications, 15100422. https://doi.org/10.1016/j.conctc.2019.100422
Ferriby, Megan, et al. "Rationale and design of a feasibility and acceptability RCT of romantic partner and support figure attendance during bariatric surgery visits." Contemporary clinical trials communications vol. 15 (2019): 100422. doi: https://doi.org/10.1016/j.conctc.2019.100422
Ferriby M, Pratt K, Wallace L, Focht BC, Noria S, Needleman B. Rationale and design of a feasibility and acceptability RCT of romantic partner and support figure attendance during bariatric surgery visits. Contemp Clin Trials Commun. 2019 Jul 24;15:100422. doi: 10.1016/j.conctc.2019.100422. eCollection 2019 Sep. PMID: 31388601; PMCID: PMC6676458.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 861 entries